First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.

Name: First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
Author: Doi, Toshihiko

First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. — المؤلف: Doi, Toshihiko — Investigational new drugs 20200220

المؤلف: Doi, Toshihiko
النشر: Investigational new drugs 20200220
الوصف: 507-518 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antimetabolites, Antineoplastic؛ Drug Combinations؛ Drug Therapy, Combination؛ Enzyme Inhibitors؛ Female